Debie J. Hoivik

1.3k total citations
25 papers, 1.1k citations indexed

About

Debie J. Hoivik is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Debie J. Hoivik has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Debie J. Hoivik's work include Drug-Induced Hepatotoxicity and Protection (8 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Debie J. Hoivik is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (8 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Debie J. Hoivik collaborates with scholars based in United States, United Kingdom and Netherlands. Debie J. Hoivik's co-authors include Stephen Safe, Weston W. Porter, Jeong‐Eun Lee, Thu Annelise Nguyen, Stephen Safe, Steven D. Cohen, Edward A. Khairallah, Richard S. Pollenz, José E. Manautou and Cody Wilson and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Debie J. Hoivik

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debie J. Hoivik United States 14 530 387 252 215 178 25 1.1k
Stephen Safe United States 12 438 0.8× 523 1.4× 174 0.7× 92 0.4× 209 1.2× 13 1.2k
Barbara C. Spink United States 16 464 0.9× 399 1.0× 207 0.8× 374 1.7× 250 1.4× 20 1.1k
Sakina E. Eltom United States 14 343 0.6× 151 0.4× 256 1.0× 191 0.9× 234 1.3× 21 856
Sui Ke United States 10 391 0.7× 154 0.4× 242 1.0× 283 1.3× 282 1.6× 13 1.1k
Jaspreet S. Sidhu United States 21 879 1.7× 139 0.4× 256 1.0× 476 2.2× 208 1.2× 34 1.6k
Togo Ikuta Japan 20 913 1.7× 250 0.6× 257 1.0× 222 1.0× 352 2.0× 31 1.7k
V. Subbarao United States 21 589 1.1× 147 0.4× 273 1.1× 166 0.8× 230 1.3× 58 1.2k
Charles Martucci United States 13 456 0.9× 699 1.8× 232 0.9× 137 0.6× 109 0.6× 21 1.3k
Ivaylo Stoilov United States 18 670 1.3× 292 0.8× 142 0.6× 374 1.7× 101 0.6× 42 1.8k
Dujin Zhou United States 27 824 1.6× 1.0k 2.7× 293 1.2× 112 0.5× 173 1.0× 44 1.6k

Countries citing papers authored by Debie J. Hoivik

Since Specialization
Citations

This map shows the geographic impact of Debie J. Hoivik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debie J. Hoivik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debie J. Hoivik more than expected).

Fields of papers citing papers by Debie J. Hoivik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debie J. Hoivik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debie J. Hoivik. The network helps show where Debie J. Hoivik may publish in the future.

Co-authorship network of co-authors of Debie J. Hoivik

This figure shows the co-authorship network connecting the top 25 collaborators of Debie J. Hoivik. A scholar is included among the top collaborators of Debie J. Hoivik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debie J. Hoivik. Debie J. Hoivik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Żuk, Anna, Zhihai Si, Debie J. Hoivik, et al.. (2022). Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia. Journal of Pharmacology and Experimental Therapeutics. 383(1). 11–24. 17 indexed citations
3.
Campbell, James A., Debie J. Hoivik, Richard T. Miller, et al.. (2005). Evaluation of the Carcinogenic Potential of Clofibrate in the FVB/Tg.AC Mouse After Dermal Application—Part II. International Journal of Toxicology. 24(5). 327–339. 7 indexed citations
4.
Cariello, Neal F., Elizabeth H. Romach, Heidi M. Colton, et al.. (2005). Gene Expression Profiling of the PPAR-alpha Agonist Ciprofibrate in the Cynomolgus Monkey Liver. Toxicological Sciences. 88(1). 250–264. 65 indexed citations
5.
Hoivik, Debie J., Charles W. Qualls, Rosanna C. Mirabile, et al.. (2004). Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys. Carcinogenesis. 25(9). 1757–1769. 56 indexed citations
6.
7.
Nguyen, Thu Annelise, Debie J. Hoivik, Jeong‐Eun Lee, & Stephen Safe. (1999). Interactions of Nuclear Receptor Coactivator/Corepressor Proteins with the Aryl Hydrocarbon Receptor Complex. Archives of Biochemistry and Biophysics. 367(2). 250–257. 116 indexed citations
8.
Hoivik, Debie J., et al.. (1998). Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes. Nucleic Acids Research. 26(12). 3044–3052. 97 indexed citations
9.
Wilson, Cody, et al.. (1998). ALTERED PHENOTYPIC CHARACTERISTICS OF T47D HUMAN BREAST CANCER CELLS AFTER PROLONGED GROWTH IN ESTROGEN‐DEFICIENT MEDIUM. Cell Biology International. 22(9-10). 623–633. 9 indexed citations
10.
Wilson, Cody, Jane S. Thomsen, Debie J. Hoivik, et al.. (1997). Aryl Hydrocarbon (Ah) Nonresponsiveness in Estrogen Receptor-Negative MDA-MB-231 Cells Is Associated with Expression of a Variant Arnt Protein. Archives of Biochemistry and Biophysics. 346(1). 65–73. 33 indexed citations
11.
12.
Porter, Weston W., et al.. (1997). Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor. Molecular Endocrinology. 11(11). 1569–1580. 339 indexed citations
13.
Hoivik, Debie J., et al.. (1997). Estrogen Does Not Inhibit 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated Effects in MCF-7 and Hepa 1c1c7 Cells. Journal of Biological Chemistry. 272(48). 30270–30274. 56 indexed citations
14.
Hoivik, Debie J., et al.. (1996). Evidence Suggesting the 58-kDa Acetaminophen Binding Protein Is a Preferential Target for Acetaminophen Electrophile. Toxicological Sciences. 32(1). 79–86. 2 indexed citations
15.
16.
Hoivik, Debie J., Robyn L. Fisher, Klaus Brendel, et al.. (1996). Protein Arylation Precedes Acetaminophen Toxicity in a Dynamic Organ Slice Culture of Mouse Kidney. Toxicological Sciences. 34(1). 99–104. 2 indexed citations
17.
Hoivik, Debie J.. (1996). Protein Arylation Precedes Acetaminophen Toxicity in a Dynamic Organ Slice Culture of Mouse Kidney. Fundamental and Applied Toxicology. 34(1). 99–104. 16 indexed citations
18.
Hoivik, Debie J.. (1996). Evidence Suggesting the 58-kDa Acetaminophen Binding Protein Is a Preferential Target for Acetaminophen Electrophile. Fundamental and Applied Toxicology. 32(1). 79–86. 25 indexed citations
19.
Hoivik, Debie J., et al.. (1995). Gender-Related Differences in Susceptibility to Acetaminophen-Induced Protein Arylation and Nephrotoxicity in the CD-1 Mouse. Toxicology and Applied Pharmacology. 130(2). 257–271. 49 indexed citations
20.
Manautou, José E., et al.. (1994). Clofibrate Pretreatment Diminishes Acetaminophen′s Selective Covalent Binding and Hepatotoxicity. Toxicology and Applied Pharmacology. 129(2). 252–263. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen Safe Breakdown of academic impact, for papers by Barbara C. Spink Breakdown of academic impact, for papers by Sakina E. Eltom Breakdown of academic impact, for papers by Sui Ke Breakdown of academic impact, for papers by Jaspreet S. Sidhu Breakdown of academic impact, for papers by Togo Ikuta Breakdown of academic impact, for papers by V. Subbarao Breakdown of academic impact, for papers by Charles Martucci Breakdown of academic impact, for papers by Ivaylo Stoilov Breakdown of academic impact, for papers by Dujin Zhou
Rankless by CCL
2026